WHO ICTRP trial
A clinic based, Phase IIa, randomised, double-blind, placebo-controlled…
EUCTR2005-005120-13-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-005120-13-GB |
|---|---|
| Public title | A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patients with established idiopathic Parkinson’s Disease |
| Scientific title | A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patients with established idiopathic Parkinson’s Disease |
| Primary sponsor | Vectura Group plc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Hypomobility (“off” or “freezing”) episodes associated with advanced Parkinson’s disease |
| Interventions | Product Name: Apomorphine hydrochloride Product Code: VR040 Pharmaceutical Form: Inhalation powder INN or Proposed INN: apomorphine hydrochloride CAS Number: 41372-20-7 Current Sponsor code: VR040 Concentration unit: µg microgram(s)… |
| Registration date | Feb 11, 2005 |
| Target size | 24 |
| Secondary IDs | VR040/001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: